Table 3.
HPV Type | Negative | CIN1 | Relative Risk | CIN2+ | Relative Risk | |||
---|---|---|---|---|---|---|---|---|
Absolute Risk (%) | Attributable Fraction (%) | Absolute Risk (%) | Attributable Fraction (%) | Absolute Risk (%) | Attributable Fraction (%) | |||
HPV6 | 0.8 (0.6–1.0) | 0.6 (0.4–0.8) | 3.1 (1.1–8.7) | 1.3 (0.3–6.1) | 2.2 | 0.8 (0.1–4.2) | 0 | 2.2 |
HPV11 | 0.3 (0.2–0.4) | 0.1 (0.1–0.3) | 0.0 | 0 | 0 | 0.8 (0.1–4.2) | 0 | 0 |
HPV16 | 2.8 (2.4–3.3) | 2.6 (2.2–3.0) | 20.8 (14.0–24.0) | 17.4 (11.2–26.1) | 6.7 | 57.6 (40.1–65.7) | 56.2 (47.7–64.4) | 21.6 |
HPV18 | 1.1 (0.9–1.4) | 0.8 (0.6–1.1) | 8.3 (4.3–15.5) | 4.6 (1.9–10.7) | 5.8 | 6.1 (3.1–11.5) | 4.3 (1.9–9.2) | 5.4 |
HPV31 | 1.2 (0.9–1.5) | 0.9 (0.7–1.2) | 6.3 (2.9–12.9) | 2.3 (0.7–7.6) | 2.6 | 1.5 (0.4–5.4) | 1.1 (0.3–4.8) | 1.2 |
HPV33 | 0.6 (0.4–0.8) | 0.5 (0.3–0.7) | 7.3 (3.6–14.2) | 5.2 (2.3–11.5) | 10.4 | 3.8 (1.6–8.6) | 2.2 (0.7–6.3) | 4.4 |
HPV35 | 0.6 (0.4–0.8) | 0.4 (0.2–0.6) | 3.1 (1.1–8.7) | 1.2 (0.2–5.8) | 3.0 | 4.6 (2.1–9.6) | 0 | 0 |
HPV39 | 1.2 (0.9–1.5) | 0.9 (0.7–1.2) | 1.0 (0.2–5.6) | 0 | 0 | 3.0 (1.2–7.5) | 0 | 0 |
HPV45 | 0.4 (0.2–0.6) | 0.3 (0.2–0.5) | 2.1 (0.6–7.2) | 0 | 0 | 0.8 (0.1–4.2) | 0.8 (0.1–4.2) | 2.7 |
HPV51 | 1.8 (1.5–2.1) | 1.3 (1.1–1.7) | 7.3 (3.6–14.2) | 4.3 (1.7–10.3) | 3.3 | 6.1 (3.1–11.5) | 2.9 (1.1–7.4) | 2.2 |
HPV52 | 3.4 (3.0–3.9) | 3.3 (2.8–3.7) | 16.7 (10.6–25.3) | 13.1 (7.8–21.2) | 4.0 | 14.4 (9.4–21.4) | 8.5 (4.8–14.5) | 2.6 |
HPV56 | 1.3 (1.0–1.6) | 0.9 (0.7–1.2) | 6.3 (2.9–12.9) | 0 | 0 | 3.0 (1.2–7.5) | 0 | 0 |
HPV58 | 1.5 (1.2–1.8) | 1.1 (0.9–1.4) | 21.9 (14.8–31.0) | 19.4 (12.8–28.3) | 17.6 | 12.1 (7.6–18.8) | 12.0 (7.5–19.0) | 10.9 |
HPV59 | 0.7 (0.5–0.9) | 0.5 (0.3–0.7) | 2.1 (0.6–7.2) | 0 | 0 | 0.8 (0.1–4.2) | 0 | 0 |
HPV66 | 1.5 (1.2–1.8) | 1.0 (0.8–1.3) | 3.1 (1.1–8.7) | 3.1 (1.1–8.6) | 3.1 | 3.8 (1.6–8.6) | 1.2 (0.3–4.9) | 1.2 |
HPV68 | 1.1 (0.9–1.4) | 0.8 (0.6–1.1) | 2.1 (0.6–7.2) | 0 | 0 | 1.5 (0.4–5.7) | 0 | 0 |
Note: The figures in the brackets represent 95% confidence interval; cervical intraepithelial neoplasia grade 1 (CIN1); cervical intraepithelial neoplasia grade 2 or above (CIN2+).